<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>XOMA Royalty</title>
	<atom:link href="https://xoma.com/feed/" rel="self" type="application/rss+xml" />
	<link>https://xoma.com</link>
	<description>A biotech royalty aggregator</description>
	<lastBuildDate>Mon, 27 Apr 2026 23:19:43 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=6.9.4</generator>

<image>
	<url>https://xoma.com/wp-content/uploads/2019/07/cropped-android-chrome-192x192-32x32.png</url>
	<title>XOMA Royalty</title>
	<link>https://xoma.com</link>
	<width>32</width>
	<height>32</height>
</image> 
	<item>
		<title>2025 Letter to Stockholders</title>
		<link>https://xoma.com/2025-letter-to-stockholders/</link>
		
		<dc:creator><![CDATA[xomaadmin]]></dc:creator>
		<pubDate>Thu, 24 Apr 2025 03:44:02 +0000</pubDate>
				<guid isPermaLink="false">https://xoma.com/?post_type=ir_newsgallery&#038;p=2773</guid>

					<description><![CDATA[]]></description>
		
		
		
			</item>
		<item>
		<title>Ligand to Acquire XOMA Royalty, Further Accelerating Profit Growth and Strengthening Ligand’s Position as a Leading Biopharma Royalty Aggregator</title>
		<link>https://xoma.com/ir_newsgallery/ligand-to-acquire-xoma-royalty-further-accelerating-profit-growth-and-strengthening-ligands-position-as-a-leading-biopharma-royalty-aggregator/</link>
		
		<dc:creator><![CDATA[xomaadmin]]></dc:creator>
		<pubDate>Mon, 27 Apr 2026 23:19:43 +0000</pubDate>
				<guid isPermaLink="false">https://xoma.com/?post_type=ir_newsgallery&#038;p=2824</guid>

					<description><![CDATA[]]></description>
		
		
		
			</item>
		<item>
		<title>XOMA Royalty Reports 2025 Financial Results and Highlights Recent Business Achievements</title>
		<link>https://investors.xoma.com/news-events/press-releases/detail/498/xoma-royalty-reports-2025-financial-results-and-highlights</link>
		
		<dc:creator><![CDATA[xomaadmin]]></dc:creator>
		<pubDate>Wed, 18 Mar 2026 14:58:10 +0000</pubDate>
				<guid isPermaLink="false">https://xoma.com/?post_type=ir_newsgallery&#038;p=2815</guid>

					<description><![CDATA[]]></description>
		
		
		
			</item>
		<item>
		<title>XOMA Royalty Announces Closing of Tender Offer and Completed Acquisition of Generation Bio, Inc.</title>
		<link>https://investors.xoma.com/news-events/press-releases/detail/495/xoma-royalty-announces-closing-of-tender-offer-and</link>
		
		<dc:creator><![CDATA[xomaadmin]]></dc:creator>
		<pubDate>Tue, 10 Feb 2026 04:39:21 +0000</pubDate>
				<guid isPermaLink="false">https://xoma.com/?post_type=ir_newsgallery&#038;p=2770</guid>

					<description><![CDATA[]]></description>
		
		
		
			</item>
		<item>
		<title>XOMA Royalty and Takeda Execute Strategic Royalty Sharing Transaction and Amend Existing Agreement for Mezagitamab</title>
		<link>https://investors.xoma.com/news-events/press-releases/detail/493/xoma-royalty-and-takeda-execute-strategic-royalty-sharing</link>
		
		<dc:creator><![CDATA[xomaadmin]]></dc:creator>
		<pubDate>Wed, 31 Dec 2025 04:42:23 +0000</pubDate>
				<guid isPermaLink="false">https://xoma.com/?post_type=ir_newsgallery&#038;p=2771</guid>

					<description><![CDATA[]]></description>
		
		
		
			</item>
	</channel>
</rss>
